Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 265

1.

Mammary mesenchymal and fibroepithelial lesions: An illustrated cytomorphologic update with differential diagnoses.

Khattab RA, Rowe JJ, Booth CN, Sneige N, Fong N, Pantanowitz L, Oshilaja O, Brainard JA, Downs-Kelly EP, Dawson A, Sturgis CD.

Diagn Cytopathol. 2019 Oct;47(10):1100-1118. doi: 10.1002/dc.24288. Epub 2019 Jul 25. Review.

PMID:
31343114
2.

Clinical Management of Mucocele-Like Lesions of the Breast with Limited or no Epithelial Atypia on Core Biopsy: Experience from Two Institutions.

Moseley TW, Shah SS, Nguyen CV, Rosenblat J, Resetkova E, Sneige N, Brandt KR, Huo L.

Ann Surg Oncol. 2019 Oct;26(11):3478-3488. doi: 10.1245/s10434-019-07377-w. Epub 2019 Jun 11.

PMID:
31187364
3.

Clinical presentation of ductal carcinoma in situ of breast with intraluminal crystalloids: Radiologic-histologic correlation.

Jung M, Maldonado J, Schwartz MR, Sneige N, Ayala AG, Ro JY.

Ann Diagn Pathol. 2018 Dec;37:42-46. doi: 10.1016/j.anndiagpath.2018.09.001. Epub 2018 Sep 12.

PMID:
30241034
4.

Flat epithelial atypia in directional vacuum-assisted biopsy of breast microcalcifications: surgical excision may not be necessary.

McCroskey Z, Sneige N, Herman CR, Miller RA, Venta LA, Ro JY, Schwartz MR, Ayala AG.

Mod Pathol. 2018 Jul;31(7):1097-1106. doi: 10.1038/s41379-018-0035-5. Epub 2018 Feb 21.

5.

Utility of endoscopic ultrasound-guided fine-needle aspiration of regional lymph nodes that are proximal to and far from the primary distal esophageal carcinoma.

Shimodaira Y, Slack RS, Harada K, Bhutani MS, Elimova E, Staerkel GA, Sneige N, Erasmus J, Shiozaki H, Charalampakis N, Planjery V, Kaya DM, Amlashi FG, Blum MA, Skinner HD, Minsky BD, Maru DM, Hofstetter WL, Swisher SG, Mares JE, Rogers JE, Lin QD, Ross WA, Weston B, Lee JH, Ajani JA.

Oncotarget. 2017 May 23;8(45):79356-79365. doi: 10.18632/oncotarget.18119. eCollection 2017 Oct 3.

6.

Three-year risk of high-grade CIN for women aged 30 years or older who undergo baseline Pap cytology and HPV co-screening.

Guo M, Khanna A, Wang J, Dawlett MA, Kologinczak TL, Lyons GR, Bassett RL Jr, Sneige N, Gong Y, Bevers TB.

Cancer Cytopathol. 2017 Aug;125(8):644-651. doi: 10.1002/cncy.21877. Epub 2017 May 12.

7.
8.

Comparison of the accuracy of US-guided biopsy of breast masses performed with 14-gauge, 16-gauge and 18-gauge automated cutting needle biopsy devices, and review of the literature.

Huang ML, Hess K, Candelaria RP, Eghtedari M, Adrada BE, Sneige N, Fornage BD.

Eur Radiol. 2017 Jul;27(7):2928-2933. doi: 10.1007/s00330-016-4651-5. Epub 2016 Nov 14. Review.

PMID:
27844099
9.

Phase I biomarker modulation study of atorvastatin in women at increased risk for breast cancer.

Arun BK, Gong Y, Liu D, Litton JK, Gutierrez-Barrera AM, Jack Lee J, Vornik L, Ibrahim NK, Cornelison T, Hortobagyi GN, Heckman-Stoddard BM, Koenig KB, Alvarez RR, Murray JL, Valero V, Lippman SM, Brown P, Sneige N.

Breast Cancer Res Treat. 2016 Jul;158(1):67-77. doi: 10.1007/s10549-016-3849-1. Epub 2016 Jun 10.

10.

Accuracy of EasyChip HPV blot genotyping assay to detect high-risk HPV genotypes in SurePath Papanicolaou specimens.

Amy Chen YJ, Lin CY, Feng J, Cogdell D, Zhang W, Liu J, Sneige N, Gong Y, Guo M.

J Am Soc Cytopathol. 2016 Nov - Dec;5(6):351-358. doi: 10.1016/j.jasc.2016.06.001. Epub 2016 Jun 27.

PMID:
31042547
11.

Prognosis of gastric adenocarcinoma patients with various burdens of peritoneal metastases.

Shiozaki H, Elimova E, Slack RS, Chen HC, Staerkel GA, Sneige N, Shimodaira Y, Sagebiel T, Lee JH, Bhutani MS, Das P, Mansfield PF, Estrella JS, Badgwell BD, Ajani JA.

J Surg Oncol. 2016 Jan;113(1):29-35. doi: 10.1002/jso.24087. Epub 2015 Nov 25.

PMID:
26603684
12.

RTOG 9804: a prospective randomized trial for good-risk ductal carcinoma in situ comparing radiotherapy with observation.

McCormick B, Winter K, Hudis C, Kuerer HM, Rakovitch E, Smith BL, Sneige N, Moughan J, Shah A, Germain I, Hartford AC, Rashtian A, Walker EM, Yuen A, Strom EA, Wilcox JL, Vallow LA, Small W Jr, Pu AT, Kerlin K, White J.

J Clin Oncol. 2015 Mar 1;33(7):709-15. doi: 10.1200/JCO.2014.57.9029. Epub 2015 Jan 20. Erratum in: J Clin Oncol. 2015 Sep 10;33(26):2934.

13.

Ultrasound-guided fine-needle aspiration biopsy of internal mammary nodes: technique and preliminary results in breast cancer patients.

Fornage BD, Dogan BE, Sneige N, Staerkel GA.

AJR Am J Roentgenol. 2014 Aug;203(2):W213-20. doi: 10.2214/AJR.13.11148.

PMID:
25055296
14.

EZH2 expression correlates with locoregional recurrence after radiation in inflammatory breast cancer.

Debeb BG, Gong Y, Atkinson RL, Sneige N, Huo L, Gonzalez-Angulo AM, Hung MC, Valero V, Ueno NT, Woodward WA.

J Exp Clin Cancer Res. 2014 Jul 23;33:58. doi: 10.1186/s13046-014-0058-9.

15.

Web based pathology assessment in RTOG 98-04.

Woodward WA, Sneige N, Winter K, Kuerer HM, Hudis C, Rakovitch E, Smith BL, Pierce LJ, Germano I, Pu AT, Walker EM, Grisell DL, White JR, McCormick B; Radiation Therapy Oncology Group (RTOG).

J Clin Pathol. 2014 Sep;67(9):777-80.

16.

Effects of a green tea extract, Polyphenon E, on systemic biomarkers of growth factor signalling in women with hormone receptor-negative breast cancer.

Crew KD, Ho KA, Brown P, Greenlee H, Bevers TB, Arun B, Sneige N, Hudis C, McArthur HL, Chang J, Rimawi M, Cornelison TL, Cardelli J, Santella RM, Wang A, Lippman SM, Hershman DL.

J Hum Nutr Diet. 2015 Jun;28(3):272-82. doi: 10.1111/jhn.12229. Epub 2014 Mar 19.

17.

Most lobular carcinoma in situ and atypical lobular hyperplasia diagnosed on core needle biopsy can be managed clinically with radiologic follow-up in a multidisciplinary setting.

Middleton LP, Sneige N, Coyne R, Shen Y, Dong W, Dempsey P, Bevers TB.

Cancer Med. 2014 Jun;3(3):492-9. doi: 10.1002/cam4.223. Epub 2014 Mar 18.

18.

Secondary tumors of the pancreas diagnosed by endoscopic ultrasound-guided fine-needle aspiration: a 10-year experience.

Waters L, Si Q, Caraway N, Mody D, Staerkel G, Sneige N.

Diagn Cytopathol. 2014 Sep;42(9):738-43. doi: 10.1002/dc.23114. Epub 2014 Feb 19.

PMID:
24554612
19.

Comparison between cytologic examination of fungi in bronchial washings and bronchoalveolar lavage specimens and culture: a review of 100 cases with emphasis on diagnostic pitfalls.

Crumley S, Hull A, Cernoch P, Mody D, Sneige N.

J Am Soc Cytopathol. 2014 Jul - Aug;3(4):211-217. doi: 10.1016/j.jasc.2014.03.002. Epub 2014 Mar 12.

PMID:
31051688
20.

Predicting degree of benefit from adjuvant trastuzumab in NSABP trial B-31.

Pogue-Geile KL, Kim C, Jeong JH, Tanaka N, Bandos H, Gavin PG, Fumagalli D, Goldstein LC, Sneige N, Burandt E, Taniyama Y, Bohn OL, Lee A, Kim SI, Reilly ML, Remillard MY, Blackmon NL, Kim SR, Horne ZD, Rastogi P, Fehrenbacher L, Romond EH, Swain SM, Mamounas EP, Wickerham DL, Geyer CE Jr, Costantino JP, Wolmark N, Paik S.

J Natl Cancer Inst. 2013 Dec 4;105(23):1782-8. doi: 10.1093/jnci/djt321. Epub 2013 Nov 21.

21.

Benign papillomas without atypia diagnosed on core needle biopsy: experience from a single institution and proposed criteria for excision.

Nayak A, Carkaci S, Gilcrease MZ, Liu P, Middleton LP, Bassett RL Jr, Zhang J, Zhang H, Coyne RL, Bevers TB, Sneige N, Huo L.

Clin Breast Cancer. 2013 Dec;13(6):439-49. doi: 10.1016/j.clbc.2013.08.007. Epub 2013 Oct 8.

22.
23.

The role of human papillomavirus type 16/18 genotyping in predicting high-grade cervical/vaginal intraepithelial neoplasm in women with mildly abnormal Papanicolaou results.

Guo M, Gong Y, Wang J, Dawlett M, Patel S, Liu P, Bevers TB, Sneige N.

Cancer Cytopathol. 2013 Feb;121(2):79-85. doi: 10.1002/cncy.21240. Epub 2012 Dec 5.

24.

Invasive paget disease of the breast: clinicopathologic study of an underrecognized entity in the breast.

Duan X, Sneige N, Gullett AE, Prieto VG, Resetkova E, Andino LM, Wu Y, Gilcrease MZ, Bedrosian I, Dawood S, Arun B, Albarracin CT.

Am J Surg Pathol. 2012 Sep;36(9):1353-8. doi: 10.1097/PAS.0b013e318259ef7f.

PMID:
22895267
25.

Peritoneal washing cytologic analysis of ovarian serous tumors of low malignant potential to detect peritoneal implants and predict clinical outcome.

Sneige N, Thomison JB, Malpica A, Gong Y, Ensor J, Silva EG.

Cancer Cytopathol. 2012 Aug 25;120(4):238-44. doi: 10.1002/cncy.21219. Epub 2012 Jul 23.

26.
27.

Molecular evidence in support of the neoplastic and precursor nature of microglandular adenosis.

Geyer FC, Lacroix-Triki M, Colombo PE, Patani N, Gauthier A, Natrajan R, Lambros MB, Khalifeh I, Albarracin C, Orru S, Marchiò C, Sapino A, Mackay A, Weigelt B, Schmitt FC, Wesseling J, Sneige N, Reis-Filho JS.

Histopathology. 2012 May;60(6B):E115-30. doi: 10.1111/j.1365-2559.2012.04207.x. Epub 2012 Apr 4.

28.

Tumor type and single-cell/mesothelial-like cell pattern of breast carcinoma metastases in pleural and peritoneal effusions.

Antic T, Gong Y, Sneige N.

Diagn Cytopathol. 2012 Apr;40(4):311-5. doi: 10.1002/dc.21563. Epub 2010 Nov 22.

PMID:
22431319
29.

Peritoneal washing cytology in patients with BRCA1 or BRCA2 mutations undergoing risk-reducing salpingo-oophorectomies: a 10-year experience and reappraisal of its clinical utility.

Landon G, Stewart J, Deavers M, Lu K, Sneige N.

Gynecol Oncol. 2012 Jun;125(3):683-6. doi: 10.1016/j.ygyno.2012.03.009. Epub 2012 Mar 13.

30.

Value of PAX8 and WT1 Immunostaining in Confirming the Ovarian Origin of Metastatic Carcinoma in Serous Effusion Specimens.

Zhao L, Guo M, Sneige N, Gong Y.

Am J Clin Pathol. 2012 Feb;137(2):304-9. doi: 10.1309/AJCPU0FION3RKKFO.

PMID:
22261458
31.

Short-term biomarker modulation prevention study of anastrozole in women at increased risk for second primary breast cancer.

Arun B, Valero V, Liu D, Brewster A, Green M, Gutierrez-Barrera A, Akar U, Rivera E, Esteva FJ, Buzdar AU, Hortobagyi GN, Sneige N.

Cancer Prev Res (Phila). 2012 Feb;5(2):276-82. doi: 10.1158/1940-6207.CAPR-11-0346. Epub 2011 Nov 18.

32.

Phase III randomized trial of dose intensive neoadjuvant chemotherapy with or without G-CSF in locally advanced breast cancer: long-term results.

Arun BK, Dhinghra K, Valero V, Kau SW, Broglio K, Booser D, Guerra L, Yin G, Walters R, Sahin A, Ibrahim N, Buzdar AU, Frye D, Sneige N, Strom E, Ross M, Theriault RL, Vadhan-Raj S, Hortobagyi GN.

Oncologist. 2011;16(11):1527-34. doi: 10.1634/theoncologist.2011-0134. Epub 2011 Oct 31.

33.

Polycomb group protein EZH2 is frequently expressed in inflammatory breast cancer and is predictive of worse clinical outcome.

Gong Y, Huo L, Liu P, Sneige N, Sun X, Ueno NT, Lucci A, Buchholz TA, Valero V, Cristofanilli M.

Cancer. 2011 Dec 15;117(24):5476-84. doi: 10.1002/cncr.26179. Epub 2011 Jun 28.

34.

Endobronchial ultrasound-guided transbronchial needle aspiration biopsy is useful evaluating mediastinal lymphadenopathy in a cancer center.

Khazai L, Kundu UR, Jacob B, Patel S, Sneige N, Eapen GA, Morice RC, Caraway NP.

Cytojournal. 2011;8:10. doi: 10.4103/1742-6413.82022. Epub 2011 May 31.

35.

Clinical implications of margin involvement by pleomorphic lobular carcinoma in situ.

Downs-Kelly E, Bell D, Perkins GH, Sneige N, Middleton LP.

Arch Pathol Lab Med. 2011 Jun;135(6):737-43. doi: 10.1043/2010-0204-OA.1.

PMID:
21631266
36.

The utility of endobronchial ultrasound-guided transbronchial needle aspiration biopsy in the diagnosis of mediastinal lymphoproliferative disorders.

Marshall CB, Jacob B, Patel S, Sneige N, Jimenez CA, Morice RC, Caraway N.

Cancer Cytopathol. 2011 Apr 25;119(2):118-26. doi: 10.1002/cncy.20134. Epub 2011 Feb 9.

37.

Stability of HER2-positive status in breast carcinoma: a comparison between primary and paired metastatic tumors with regard to the possible impact of intervening trastuzumab treatment.

Xiao C, Gong Y, Han EY, Gonzalez-Angulo AM, Sneige N.

Ann Oncol. 2011 Jul;22(7):1547-53. doi: 10.1093/annonc/mdq623. Epub 2011 Jan 14.

PMID:
21239403
38.

Efficacy of p16 and ProExC immunostaining in the detection of high-grade cervical intraepithelial neoplasia and cervical carcinoma.

Guo M, Baruch AC, Silva EG, Jan YJ, Lin E, Sneige N, Deavers MT.

Am J Clin Pathol. 2011 Feb;135(2):212-20. doi: 10.1309/AJCP1LLX8QMDXHHO.

PMID:
21228361
39.

Paneth cell-like eosinophilic cytoplasmic granules in breast carcinoma.

Huo L, Bell D, Qiu H, Sahin A, Wu Y, Sneige N.

Ann Diagn Pathol. 2011 Apr;15(2):84-92. doi: 10.1016/j.anndiagpath.2010.08.007. Epub 2010 Dec 16.

PMID:
21163678
40.

Identifying patients with atypical ductal hyperplasia diagnosed at core-needle biopsy who are at low risk of malignancy.

Albarracin CT, Nguyen CV, Whitman GJ, Yang W, Sneige N.

Radiology. 2010 Dec;257(3):893-4; author reply 984. doi: 10.1148/radiol.101253. No abstract available. Erratum in: Radiology. 2011 Mar;258(3):962. Weiang, Wei [corrected to Yang, Wei].

PMID:
21084420
41.

Atypical ductal hyperplasia in directional vacuum-assisted biopsy of breast microcalcifications: considerations for surgical excision.

Nguyen CV, Albarracin CT, Whitman GJ, Lopez A, Sneige N.

Ann Surg Oncol. 2011 Mar;18(3):752-61. doi: 10.1245/s10434-010-1127-8. Epub 2010 Oct 23.

PMID:
20972636
42.

Stability of estrogen receptor status in breast carcinoma: a comparison between primary and metastatic tumors with regard to disease course and intervening systemic therapy.

Gong Y, Han EY, Guo M, Pusztai L, Sneige N.

Cancer. 2011 Feb 15;117(4):705-13. doi: 10.1002/cncr.25506. Epub 2010 Oct 11.

43.

A nomogram to predict for malignant diagnosis of BI-RADS Category 4 breast lesions.

Mazouni C, Sneige N, Rouzier R, Balleyguier C, Bevers T, André F, Vielh P, Delaloge S.

J Surg Oncol. 2010 Sep 1;102(3):220-4. doi: 10.1002/jso.21616.

PMID:
20740578
44.

Expression of high-molecular-weight cytokeratin (34betaE12) is an independent predictor of disease-free survival in patients with triple-negative tumours of the breast.

Mehta R, Jain RK, Sneige N, Badve S, Resetkova E.

J Clin Pathol. 2010 Aug;63(8):744-7. doi: 10.1136/jcp.2010.076653.

PMID:
20702478
45.

Evaluation of p16 immunostaining to predict high-grade cervical intraepithelial neoplasia in women with Pap results of atypical squamous cells of undetermined significance.

Guo M, Warriage I, Mutyala B, Patel S, Lin E, Gong Y, Sneige N.

Diagn Cytopathol. 2011 Jul;39(7):482-8. doi: 10.1002/dc.21415. Epub 2010 Jul 6.

PMID:
20607682
46.

Is it too soon to start reporting HER2 genetic heterogeneity?

Albarracin C, Edgerton ME, Gilcrease MZ, Huo L, Krishnamurthy S, Middleton LP, Resetkova E, Sahin AA, Sneige N, Fraser WS, Wu Y.

Arch Pathol Lab Med. 2010 Feb;134(2):162-3; author reply 163. doi: 10.1043/1543-2165-134.2.162.b. No abstract available. Erratum in: Arch Pathol Lab Med. 2010 Apr;134(4):500.

PMID:
20121597
47.

Performance of chromogenic in situ hybridization on testing HER2 Status in breast carcinomas with chromosome 17 polysomy and equivocal (2+) herceptest results: a study of two institutions using the conventional and new ASCO/CAP scoring criteria.

Gong Y, Sweet W, Duh YJ, Greenfield L, Tarco E, Trivedi S, Symmans WF, Isola J, Sneige N.

Am J Clin Pathol. 2009 Aug;132(2):228-36. doi: 10.1309/AJCP4M2VUZCLDALN.

PMID:
19605817
48.

Immunohistochemical characterization of subtypes of male breast carcinoma.

Ge Y, Sneige N, Eltorky MA, Wang Z, Lin E, Gong Y, Guo M.

Breast Cancer Res. 2009;11(3):R28. doi: 10.1186/bcr2258. Epub 2009 May 14.

50.

Chromogenic in situ hybridization is a reliable method for detecting HER2 gene status in breast cancer: a multicenter study using conventional scoring criteria and the new ASCO/CAP recommendations.

Gong Y, Sweet W, Duh YJ, Greenfield L, Fang Y, Zhao J, Tarco E, Symmans WF, Isola J, Sneige N.

Am J Clin Pathol. 2009 Apr;131(4):490-7. doi: 10.1309/AJCPI00TVGIGYXAA.

PMID:
19289584

Supplemental Content

Loading ...
Support Center